BDP/FF Versus Formoterol Fumarate (FF) in Patients With Severe COPD (Lung Function and Exacerbation Rate)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Chiesi Farmaceutici S.p.A.
ClinicalTrials.gov Identifier:
NCT00929851
First received: June 29, 2009
Last updated: August 2, 2013
Last verified: August 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2012
  Primary Completion Date: March 2012 (Final data collection date for primary outcome measure)
No publications provided by Chiesi Farmaceutici S.p.A.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):